Most Read Articles
Roshini Claire Anthony, 05 Oct 2017

Olfactory impairment in older adults may point to an elevated risk of developing Parkinson’s disease (PD), particularly in Caucasian men, a small US study found.

Elvira Manzano, Yesterday
Bisphosphonates have proven antifracture efficacy and remain to be the cornerstone of osteoporosis treatment. However, a drug holiday is of particular importance with bisphosphonates due to some signals with long-term use of the drug, including rare incidence of atypical femoral fracture (AFF) and osteonecrosis of the jaw (ONJ), says a leading endocrinologist at AFOS 2017.
07 Oct 2017
Women who follow a low-fat dietary pattern appear to have reduced breast cancer mortality, according to data from the Earlier Women’s Health Initiative Dietary Modification trial.
Pearl Toh, 5 days ago
Women with higher plasma tryptophan concentrations were less likely to have poor sleep quality during pregnancy, especially among those with anxiety symptoms, according to the GUSTO* study.

Corticosteroids with moxifloxacin effective against ACC with SLE

03 Aug 2017

Corticosteroids combined with the antibiotic moxifloxacin may be effective for the management of acute acalculous cholecystitis (AAC) with systemic lupus erythematosus (SLE), suggests a new observational study.

The investigators recruited 22 AAC patients with SLE who were receiving conservative management of either moxifloxacin alone (n=10; mean age 36.1±16.3 years) or in combination with corticosteroids (n=12; mean age 34.7±11.0 years). Study outcomes included improvement of symptoms and biochemical results, disease response and surgery.

The Systemic Lupus Erythematosus Disease Activity Index (SLEDAI-2000) scores were significantly lower in the corticosteroid group than in the antibiotic alone group (7.3±1.4 vs 10.7±3.0; p=0.03). A similar trend was observed with the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index (SLICC/ACR) scores (0.1±0.3 vs 0.3±0.5; p=0.01).

The levels of antinuclear antibodies (1.3±0.4 vs 2.1±0.6 IU/mL; p=0.03), antidouble stranded DNA antibodies (40.0±8.3 vs 145.4±25.5 IU/mL; p=0.04) and anticardiolipin antibodies (17.9±4.5 vs 46.8±13.7 IU/mL; p=0.01) were significantly lower in the corticosteroid group than in the antibiotic group.

Significantly more patients in the corticosteroid group showed a positive response (p=0.01) and 11 of 12 patients were treated successfully. Only one patient in the corticosteroid group underwent cholecystectomy after treatment yielded no improvements.

By comparison, only four of 10 patients in the antibiotic alone group were successfully treated, and the remaining six had to undergo cholecystectomy because treatment conferred no improvements.

The rate of successful conservative treatment was thus significantly greater in the corticosteroid group than in the antibiotic group (p=0.02).

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 05 Oct 2017

Olfactory impairment in older adults may point to an elevated risk of developing Parkinson’s disease (PD), particularly in Caucasian men, a small US study found.

Elvira Manzano, Yesterday
Bisphosphonates have proven antifracture efficacy and remain to be the cornerstone of osteoporosis treatment. However, a drug holiday is of particular importance with bisphosphonates due to some signals with long-term use of the drug, including rare incidence of atypical femoral fracture (AFF) and osteonecrosis of the jaw (ONJ), says a leading endocrinologist at AFOS 2017.
07 Oct 2017
Women who follow a low-fat dietary pattern appear to have reduced breast cancer mortality, according to data from the Earlier Women’s Health Initiative Dietary Modification trial.
Pearl Toh, 5 days ago
Women with higher plasma tryptophan concentrations were less likely to have poor sleep quality during pregnancy, especially among those with anxiety symptoms, according to the GUSTO* study.